Related references
Note: Only part of the references are listed.The role of integrated positron emission tomography and computed tomography in the assessment of nodal spread in cases with non-small cell lung cancer
Erdal Tasci et al.
INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY (2010)
Standard Uptake Value Predicts Survival in Non-Small Cell Lung Cancer
Ikenna C. Okereke et al.
ANNALS OF THORACIC SURGERY (2009)
Synthesis and evaluation of novel F-18 labeled fluoroarylvaline derivatives: Potential PET imaging agents for tumor detection
Yali Qiao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Impact of clinical factors, including a point-of-care nuclear matrix protein-22 assay and cytology, on bladder cancer detection
Yair Lotan et al.
BJU INTERNATIONAL (2009)
A decade of genome-wide gene expression profiling in acute myeloid leukemia: flashback and prospects
Bas J. Wouters et al.
BLOOD (2009)
Oral tongue cancer gene expression profiling: Identification of novel potential prognosticators by oligonucleotide microarray analysis
Cherry L. Estilo et al.
BMC CANCER (2009)
A longitudinal study of gene expression in healthy individuals
Chris Karlovich et al.
BMC MEDICAL GENOMICS (2009)
Analysis of differential gene expression in colorectal cancer and stroma using fluorescence-activated cell sorting purification
M. J. Smith et al.
BRITISH JOURNAL OF CANCER (2009)
New Molecular Classifications of Breast Cancer
Mary Cianfrocca et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT) Imaging in the Staging and Prognosis of Inflammatory Breast Cancer
Jean-Louis Alberini et al.
CANCER (2009)
Intrinsic Gene Expression Profiles of Gliomas Are a Better Predictor of Survival than Histology
Lonneke A. M. Gravendeel et al.
CANCER RESEARCH (2009)
Combination of alpha-1-acid glycoprotein and alpha-fetoprotein as an improved diagnostic tool for hepatocellular carcinoma
Indra Bachtiar et al.
CLINICA CHIMICA ACTA (2009)
Prediction of breast cancer metastasis by genomic profiling: where do we stand?
Ulrich Pfeffer et al.
CLINICAL & EXPERIMENTAL METASTASIS (2009)
Imaging Biomarkers Predict Response to Anti-HER2 (ErbB2) Therapy in Preclinical Models of Breast Cancer
Chirayu Shah et al.
CLINICAL CANCER RESEARCH (2009)
Imaging Mass Spectrometry of a Specific Fragment of Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Kinase Kinase 2 Discriminates Cancer from Uninvolved Prostate Tissue
Lisa H. Cazares et al.
CLINICAL CANCER RESEARCH (2009)
PCR-Based Methods for Detecting Single-Locus DNA Methylation Biomarkers in Cancer Diagnostics, Prognostics, and Response to Treatment
Lasse Sommer Kristensen et al.
CLINICAL CHEMISTRY (2009)
Prediction of Progression-Free Survival in Patients With Multiple Myeloma Following Anthracycline-Based Chemotherapy Based on Dynamic FDG-PET
Antonia Dimitrakopoulou-Strauss et al.
CLINICAL NUCLEAR MEDICINE (2009)
Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications
D. P. Soares et al.
CLINICAL RADIOLOGY (2009)
Prostate cancer biomarker discovery using high performance mass spectral serum profiling
Jung Hun Oh et al.
COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2009)
Metabolite Quantification in Tumours by Magnetic Resonance Spectroscopy: Objectives, Results and Perspectives
Rossella Canese et al.
Current Medical Imaging Reviews (2009)
68Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin αvβ3 PET imaging
Zhaofei Liu et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
[18F]Fluoroacetate is not a functional analogue of [11C]acetate in normal physiology
Orjan Lindhe et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2009)
PET/CT for the staging and follow-up of patients with malignancies
T. D. Poeppel et al.
EUROPEAN JOURNAL OF RADIOLOGY (2009)
α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma
Jorge A. Marrero et al.
GASTROENTEROLOGY (2009)
Identification of methods for use of formalin-fixed, paraffin-embedded tissue samples in RNA expression profiling
Lisa Roberts et al.
GENOMICS (2009)
Tumor microRNA expression patterns associated with resistance to platinum based chemotherapy and survival in ovarian cancer patients
Ram Eitan et al.
GYNECOLOGIC ONCOLOGY (2009)
Highly sensitive detection of melanoma based on serum proteomic profiling
Julie Caron et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2009)
MicroRNA Expression in Melanocytic Nevi: The Usefulness of Formalin-Fixed, Paraffin-Embedded Material for miRNA Microarray Profiling
Martin Glud et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers
D. G. Evans et al.
JOURNAL OF MEDICAL GENETICS (2009)
A novel approach for reliable microarray analysis of microdissected tumor cells from formalin-fixed and paraffin-embedded colorectal cancer resection specimens
Silke Lassmann et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2009)
Detection of Aggressive Primary Prostate Cancer with 11C-Choline PET/CT Using Multimodality Fusion Techniques
Morand Piert et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Metabolic alterations in the peritumoral brain in cases of meningiomas: 1H-MRS study
Mikhail F. Chernov et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Study of normal breast tissue by in vivo volume localized proton MR Spectroscopy: variation of Water-Fat ratio in relation to the heterogeneity of the breast and the menstrual cycle
Uma Sharma et al.
MAGNETIC RESONANCE IMAGING (2009)
High Spatial Resolution 1H Magnetic Resonance Spectroscopic Imaging Of Human Breast Cancer At 3T
W. Feng et al.
MEDICAL PHYSICS (2009)
Molecular imaging of cell death
Marijke De Saint-Hubert et al.
METHODS (2009)
Molecular imaging of proliferation in vivo: Positron emission tomography with [18F]fluorothymidine
Andreas K. Buck et al.
METHODS (2009)
MOLECULAR ORIGINS OF CANCER Gene-Expression Signatures in Breast Cancer
Christos Sotiriou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Metabolite quantification and high-field MRS in breast cancer
Ihab S. Haddadin et al.
NMR IN BIOMEDICINE (2009)
Proton MRS of the breast in the clinical setting
Carolyn Mountford et al.
NMR IN BIOMEDICINE (2009)
Evaluation of O-[18F]fluoromethyl-D-tyrosine as a radiotracer for tumor imaging with positron emission tomography
Takeo Urakami et al.
NUCLEAR MEDICINE AND BIOLOGY (2009)
Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties
C. Coulouarn et al.
ONCOGENE (2009)
[F-18]- and [C-11]-Labeled N-benzyl-isatin sulfonamide analogues as PET tracers for Apoptosis: synthesis, radiolabeling mechanism, and in vivo imaging study of apoptosis in Fas-treated mice using [C-11]WC-98
Dong Zhou et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2009)
Generation of hyperpolarized substrates by secondary labeling with [1,1-13C] acetic anhydride
David M. Wilson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Positron emission tomography imaging of drug-induced tumor apoptosis with a caspase-3/7 specific [18F]-labeled isatin sulfonamide
Quang-De Nguyen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Biomedical applications of hyperpolarized 13C magnetic resonance imaging
F. A. Gallagher et al.
PROGRESS IN NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY (2009)
Mass spectrometry in clinical proteomics - from the present to the future
Magnus Palmblad et al.
PROTEOMICS CLINICAL APPLICATIONS (2009)
Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancer
Emile Tan et al.
SURGICAL ONCOLOGY-OXFORD (2009)
Evolving molecular classification by genomic and proteomic biomarkers in colorectal cancer: Potential implications for the surgical oncologist
Kjetil Soreide et al.
SURGICAL ONCOLOGY-OXFORD (2009)
Repeat prostate biopsy-when, where, and how
Joseph C. Presti
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2009)
Risk of Developing Prostate Cancer in the Future: Overview of Prognostic Biomarkers
Neil E. Fleshner et al.
UROLOGY (2009)
The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?
Vladimir Nossov et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2008)
Dual-Time-Point 18F-FDG PET/CT Versus Dynamic Breast MRI of Suspicious Breast Lesions
Massimo Imbriaco et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2008)
The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET
Hung-Jen Hsieh et al.
ANNALS OF NUCLEAR MEDICINE (2008)
MRI and 1H MRS of The Breast: Presence of a Choline Peak as Malignancy Marker is Related to k21 Value of the Tumor in Patients with Invasive Ductal Carcinoma
Patricia R. Geraghty et al.
BREAST JOURNAL (2008)
Hyperpolarized 13C Lactate, Pyruvate, and Alanine: Noninvasive Biomarkers for Prostate Cancer Detection and Grading
Mark J. Albers et al.
CANCER RESEARCH (2008)
Salivary Proteomics for Oral Cancer Biomarker Discovery
Shen Hu et al.
CLINICAL CANCER RESEARCH (2008)
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
Catharine M. Sturgeon et al.
CLINICAL CHEMISTRY (2008)
Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues
Anna E. y Szafranska et al.
CLINICAL CHEMISTRY (2008)
Utilization of genomic signatures to direct use of primary chemotherapy
Anil Potti et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2008)
Individualized Treatment Planning in Oncology: Role of PET and Radiolabelled Anticancer Drugs in Predicting Tumour Resistance
Astrid A. M. van der Veldt et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
PET imaging with 11C-acetate in prostate cancer:: a biochemical, radiochemical and clinical perspective
Dmitri Soloviev et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer
Alessandro Sciarra et al.
EUROPEAN UROLOGY (2008)
Trial Assessing Individualized Options for Treatment for breast cancer: the TAILORx trial
Jo Anne Zujewski et al.
FUTURE ONCOLOGY (2008)
An integrated cross-platform prognosis study on neuroblastoma patients
Qing-Rong Chen et al.
GENOMICS (2008)
Review: Biological relevance of disseminated tumor cells in cancer patients
Sabine Riethdorf et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Diagnostic and prognostic implications of microRNAs in human hepatocellular carcinoma
Wenxi Li et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Usefulness of the serum carcinoembryonic antigen kinetic for chemotherapy monitoring in patients with unresectable metastasis of colorectal cancer
Isabelle Iwanicki-Caron et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Latest advances in molecular imaging instrumentation
Bernd J. Pichler et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
A multicenter clinical trial on the diagnostic value of dual-tracer PET/CT in pulmonary lesions using 3′-deoxy-3′-18F-fluorothymidine and 18F-FDG
Jiahe Tian et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Reproducibility of mass spectrometry based protein profiles for diagnosis of breast cancer across clinical studies: A systematic review
Anne K. Callesen et al.
JOURNAL OF PROTEOME RESEARCH (2008)
11C-Acetate can be Used in Place of 18F-Fluorodeoxyglucose for Positron Emission Tomography Imaging of Non-small Cell Lung Cancer with Higher Sensitivity for Well-Differentiated Adenocarcinoma
Hiroaki Nomori et al.
JOURNAL OF THORACIC ONCOLOGY (2008)
C-11-acetate PET in the evaluation of brain glioma: Comparison with C-11-methionine and F-18-FDG-PET
Y. Yamamoto et al.
MOLECULAR IMAGING AND BIOLOGY (2008)
Proton magnetic resonance spectroscopy of the central, transition and peripheral zones of the prostate: assignments and correlation with histopathology
Peter Swindle et al.
MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE (2008)
MicroRNAs accurately identify cancer tissue origin
Nitzan Rosenfeld et al.
NATURE BIOTECHNOLOGY (2008)
Molecular origins of cancer: Epigenetics in cancer
Manel Esteller
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Early Detection of Erlotinib Treatment Response in NSCLC by 3′-Deoxy-3′-[18F]-Fluoro-L-Thymidine ([18F]FLT) Positron Emission Tomography (PET)
Roland T. Ullrich et al.
PLOS ONE (2008)
Detection of cell death in tumors by using MR imaging and a gadolinium-based targeted contrast agent
Anant S. Krishnan et al.
RADIOLOGY (2008)
Mucins CA 125, CA 19.9, CA 15.3 and TAG-72.3 as Tumor Markers in Patients with Lung Cancer: Comparison with CYFRA 21-1, CEA, SCC and NSE
Rafael Molina et al.
TUMOR BIOLOGY (2008)
The hybrid SPECT/CT as an additional lymphatic mapping tool in patients with breast cancer
Iris M. C. van der Ploeg et al.
WORLD JOURNAL OF SURGERY (2008)
New approaches for imaging tumour responses to treatment
Kevin Brindle
NATURE REVIEWS CANCER (2008)
Analytical validation of serum proteomic profiling for diagnosis of prostate cancer: Sources of sample bias
Dale McLerran et al.
CLINICAL CHEMISTRY (2008)
C-11-L-methionine positron emission tomography in the clinical management of cerebral gliomas
Tarun Singhal et al.
MOLECULAR IMAGING AND BIOLOGY (2008)
Panel of serum biomarkers for the diagnosis of lung cancer
Edward F. Patz et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
The impact of 18F-FDG PET/CT in patients with liver metastases
Siew C. Chua et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Alpha fetoprotein, ultrasound, computerized tomography and magnetic resonance imaging for detection of hepatocellular carcinoma in patients with advanced cirrhosis
N. Snowberger et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2007)
Detecting tumor response to treatment using hyperpolarized 13C magnetic resonance imaging and spectroscopy
Sam E. Day et al.
NATURE MEDICINE (2007)
Processing of generator-produced 68Ga for medical application
Konstantin P. Zhernosekov et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy
Carlo Capirci et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours
I. Buchmann et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Proton MR spectroscopy of the prostate
Ullrich G. Mueller-Lisse et al.
EUROPEAN JOURNAL OF RADIOLOGY (2007)
Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury
Qing-Shi Zeng et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients
Guillaume Guichard et al.
EUROPEAN UROLOGY (2007)
Mass spectrometry to classify non-small-cell lung cancer patients for clinical outcome after treatment with epidermal growth factor receptor tyrosine kinase inhibitors: A multicohort cross-institutional study
Fumiko Taguchi et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Fluorine-18 fluorodeoxyglucose PET in the preoperative staging of colorectal cancer
Jose Manuel Llamas-Elvira et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use
M. J. Duffy et al.
EUROPEAN JOURNAL OF CANCER (2007)
Abnormal choline phospholipid metabolism in breast and ovary cancer: Molecular bases for noninvasive imaging approaches
Franca Podo et al.
CURRENT MEDICAL IMAGING (2007)
CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence:: a combined analysis of seven International Breast Cancer Study Group trials
A. Keshaviah et al.
ANNALS OF ONCOLOGY (2007)
Prognostic value of O-(2-18F-fluoroethyl)-L-tyrosine PET and MRI in low-grade glioma
Frank W. Floeth et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
PET/CT: Form and function
Todd M. Blodgett et al.
RADIOLOGY (2007)
Magnetic resonance spectroscopy in patients with locally confined prostate cancer: association of prostatic citrate and metabolic atrophy with time on hormone deprivation therapy, PSA level, and biopsy Gleason score
Ullrich G. Mueller-Lisse et al.
EUROPEAN RADIOLOGY (2007)
Dynamics of tumor hypoxia measured with bioreductive hypoxic cell markers
Anna S. E. Ljungkvist et al.
RADIATION RESEARCH (2007)
Utilization of glutamate/creatine ratios for proton spectroscopic diagnosis of meningiomas
Saman Hazany et al.
NEURORADIOLOGY (2007)
Transcriptional profiling of hematologic malignancies with a low-density DNA microarray
Patricia Alvarez et al.
CLINICAL CHEMISTRY (2007)
Prostate cancer screening decreases the absolute risk of being diagnosed with advanced prostate cancer - Results from a prospective, population-based randomized controlled trial
Gunnar Aus et al.
EUROPEAN UROLOGY (2007)
In vivo proton magnetic resonance spectroscopy of breast lesions: an update
Gary M. Tse et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
Genomics and proteomics: Emerging technologies in clinical cancer research
Christine H. Chung et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2007)
Intensive post-operative follow-up of breast cancer patients with tumour markers: CEA, TPA or CA15.3 vs MCA and MCA-CA15.3 vs CEA-TPA-CA15.3 panel in the early detection of distant metastases
Andrea Nicolini et al.
BMC CANCER (2006)
Molecular Imaging of proliferation in malignant lymphoma
Andreas K. Buck et al.
CANCER RESEARCH (2006)
PET/CT in patients with hepatocellular carcinoma using [18F] fluorocholine:: preliminary comparison with [18F]FDG PET/CT
Jean-Noël Talbot et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
Prostate cancer localization with dynamic contrast-enhanced MR imaging and proton MR spectroscopic imaging
Jurgen J. Fuetterer et al.
RADIOLOGY (2006)
Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy
Sophia Koukouraki et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
Comparison of 18F-fluoromethylcholine and 2-deoxy-D-glucose in the distribution of tumor and inflammation
Kazuo Kubota et al.
ANNALS OF NUCLEAR MEDICINE (2006)
Monitoring the therapeutic response of locally advanced breast cancer patients: Sequential in vivo proton MR spectroscopy study
Mahesh Kumar et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2006)
Positron emission tomography as an imaging biomarker
Wolfgang A. Weber
JOURNAL OF CLINICAL ONCOLOGY (2006)
Dynamic contrast-enhanced magnetic resonance imaging as an imaging biomarker
Nola Hylton
JOURNAL OF CLINICAL ONCOLOGY (2006)
αvβ3-integrin imaging:: a new approach to characterise angiogenesis?
Roland Haubner
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
How few cancer cells can be detected by positron emission tomography? A frequent question addressed by an in vitro study
BM Fischer et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
Development of a decision support system for diagnosis and grading of brain tumours using in vivo magnetic resonance single voxel spectra
Anne R. Tate et al.
NMR IN BIOMEDICINE (2006)
2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography/computed tomography imaging evaluation of esophageal cancer
Hossein Jadvar et al.
MOLECULAR IMAGING AND BIOLOGY (2006)
In vivo research in astrocytoma cell proliferation with 1H-magnetic resonance spectroscopy:: correlation with histopathology and immunohistochemistry
Jun Chen et al.
NEURORADIOLOGY (2006)
PET imaging of brain astrocytoma with 1-11C-acetate
RS Liu et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
N Yanaihara et al.
CANCER CELL (2006)
Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy
DJ Manton et al.
BRITISH JOURNAL OF CANCER (2006)
Functional genomics of hepatocellular carcinoma
SS Thorgeirsson et al.
HEPATOLOGY (2006)
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
AH Bild et al.
NATURE (2006)
FDG-PET and CT characterization of adrenal lesions in cancer patients
S Jana et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2006)
Choline phospholipid metabolism in cancer: Consequences for molecular pharmaceutical interventions
Kristine Glunde et al.
MOLECULAR PHARMACEUTICS (2006)
Applications of magnetic resonance spectroscopy in radiotherapy treatment planning
G. S. Payne et al.
BRITISH JOURNAL OF RADIOLOGY (2006)
Proton MRS imaging in the follow-up of patients with suspected low-grade gliomas
JC Reijneveld et al.
NEURORADIOLOGY (2005)
Active surveillance for prostate cancer: For whom?
L Klotz
JOURNAL OF CLINICAL ONCOLOGY (2005)
Characterization of serum biomarkers for detection of early stage ovarian cancer
KR Kozak et al.
PROTEOMICS (2005)
Colon cancer prognosis prediction by gene expression profiling
A Barrier et al.
ONCOGENE (2005)
Carbon-11 labeled σ2 receptor ligands for imaging breast cancer
ZD Tu et al.
NUCLEAR MEDICINE AND BIOLOGY (2005)
[18F]3′-deoxy-3′-fluorothymidine PET for the diagnosis and grading of brain tumors
SJ Choi et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
Quantitative biochemical analysis of lactate dehydrogenase in human ovarian tissues: correlation with tumor grade
S Simaga et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2005)
Functional diffusion map: A noninvasive MR1 biomarker for early stratification of clinical brain tumor response
BA Moffat et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Clinical relevance of imaging proliferative activity in lung nodules
AK Buck et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
Correlation of proton MR spectroscopic imaging with Gleason score based on step-section pathologic analysis after radical prostatectomy
KL Zakian et al.
RADIOLOGY (2005)
O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas
D Pauleit et al.
BRAIN (2005)
The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer
XG Ni et al.
EJSO (2005)
Matrix metalloproteinases as diagnostic (MMP-13) and prognostic (MMP-2, MMP-9) markers of prostate cancer
G Morgia et al.
UROLOGICAL RESEARCH (2005)
Proton magnetic resonance spectroscopy of brain tumors correlated with pathology
A Magalhaes et al.
ACADEMIC RADIOLOGY (2005)
Clinical applications of microarray technology: creatine kinase B is an up-regulated gene in epithelial ovarian cancer and shows promise as a serum marker
HG Huddleston et al.
GYNECOLOGIC ONCOLOGY (2005)
Proton magnetic resonance spectroscopy with a body coil in the diagnosis of carcinoma prostate
R Kumar et al.
UROLOGICAL RESEARCH (2004)
Sigma receptors and cancer: Possible involvement of ion channels
E Aydar et al.
CANCER RESEARCH (2004)
Increase in signal-to-noise ratio of >10,000 times in liquid-state NMR
JH Ardenkjaer-Larsen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
18FDG-Positron emission tomography for the early prediction of response in advanced soft tissue sarcoma treated with imatinib mesylate (Glivec®)
S Stroobants et al.
EUROPEAN JOURNAL OF CANCER (2003)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
Share Paper
